文献速递甲状腺疾病

低风险甲状腺微小乳头状癌主动监测后转手术率随时间显著下降

Marked Decrease Over Time in Conversion Surgery After Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma.
PubMed 文献 · Thyroid · 2020-08-19

研究纳入2288例接受主动监测的低风险甲状腺微小乳头状癌(PMC)患者,162例(7.1%)在启动监测12个月后因疾病进展、患者意愿、医生偏好等原因接受转手术。按监测启动时间分为前半组(2005年2月-2011年11月;561例)和后半组(2011年12月-2017年6月;1727例),后半组转手术率显著低于前半组,且在各原因亚组中均显著降低。

要点

  • 2288例低风险PMC主动监测患者中,162例(7.1%)在12个月后转手术。
  • 后半组(2011年12月-2017年6月)转手术率显著低于前半组(2005年2月-2011年11月)。
  • 患者意愿、医生偏好和疾病进展三个亚组的转手术率在后半组均显著更低。

核心结论

  • 后半组PMC患者因任何原因接受转手术的可能性均显著低于前半组,可能源于主动监测良好结局数据的积累增强了医生的信心及患者的信任与理解。

研究设计与样本

  • 纳入2288例接受主动监测的PMC患者,其中162例(7.1%)在启动监测12个月后接受转手术。
  • 转手术原因包括疾病进展57例、患者意愿43例、医生偏好31例、其他相关甲状腺或甲状旁腺疾病24例及其他原因7例。
  • 按监测启动时间分为前半组(2005年2月-2011年11月;561例)和后半组(2011年12月-2017年6月;1727例)。

主要发现

  • 前半组与后半组之间PMC进展标准无差异。
  • 医生偏好组女性患者比例显著高于疾病进展组和患者意愿组。
  • 疾病进展组手术时肿瘤尺寸大于其他两组,肿瘤体积倍增率高于其他两组。
  • 后半组患者接受转手术的可能性显著低于前半组。
  • 在患者意愿、医生偏好和疾病进展亚组中,后半组转手术率均显著低于前半组。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Active surveillance for low-risk papillary microcarcinoma (PMC) of the thyroid is an accepted and safe management strategy. However, some patients undergo conversion surgery after the initiation of active surveillance for various reasons. We investigated the reasons for conversion surgery and whether and how they changed over time. Methods: We enrolled 2288 patients with PMC who underwent active surveillance. Of these, 162 (7.1%) underwent conversion surgery >12 months after initiating active surveillance due to disease progression (57 patients), patient preference (43 patients), physician preference (31 patients), other associated thyroid or parathyroid diseases (24 patients), and other reasons (7 patients). We analyzed cumulative conversion rates not only in the whole cohort but also in the first three major subsets based on the reasons for surgery. We also divided our whole cohort into two groups based on the period of active surveillance commencement: the first-half group (February 2005-November 2011; 561 patients) and the second-half group (December 2011-June 2017; 1727 patients). Results: The criteria for PMC progression did not differ between the first- and second-half groups. The proportion of female patients in the physician preference group was significantly higher than that in the disease progression and the patient preference groups. Tumor size at surgery was larger, and tumor volume-doubling rate was higher in the disease progression group than in the other two groups. Patients in the second-half group were significantly less likely to undergo conversion surgery than those in the first-half group. Furthermore, conversion surgery rates in the second-half group were significantly lower than those in the first-half group in the patient preference, physician preference, and disease progression groups. Conclusions: Patients with PMC in the second-half group were significantly less likely to undergo conversion surgery than those in the first-half group regardless of the reason. This is probably because data accumulation of favorable outcomes with active surveillance significantly contributed to physicians' confidence and patients' trust and understanding of this disease.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Sasaki T, Miyauchi A, Ito Y, et al. Marked Decrease Over Time in Conversion Surgery After Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma. Thyroid. 2020. PMID: 32664805. doi:10.1089/thy.2020.0319

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。